Opinion
No. S233898.
06-08-2016
H. (T.) v. NOVARTIS PHARMACEUTICALS CORPORATION.
The applications to appear as counsel pro hac vice are granted. The petition for review is granted. The issue to be briefed and argued is limited to the following: May the brand name manufacturer of a pharmaceutical drug that divested all ownership interest in the drug be held liable for injuries caused years later by another manufacturer's generic version of that drug?
WERDEGAR, J., was recused and did not participate.
CANTIL–SAKAUYE, C.J., CHIN, CORRIGAN, LIU, CUÉLLAR, and KRUGER, JJ., concur.